Orchestra BioMed
OBIO
OBIO
43 hedge funds and large institutions have $70.3M invested in Orchestra BioMed in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 1 closing their positions.
Holders
43
Holders Change
+4
Holders Change %
+10.26%
% of All Funds
0.62%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
13
Reduced
17
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$3.01M |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$23.4K |
3 |
3
Morgan Stanley
New York
|
$98.4K |
4 |
4
State Street
Boston,
Massachusetts
|
$1.34M |
5 |
5
BlackRock
New York
|
$7.6M |